Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other solid neoplasm 1

Conditions

Prostatic Neoplasms 1Mesothelioma, Malignant 1Kidney Neoplasms 1

Interventions

pembrolizumab 592Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 508Specimen Handling 504Nivolumab 408Cisplatin 370Carboplatin 359Biopsy 304Blood Specimen Collection 295Radiosurgery 284Paclitaxel 274Surveys and Questionnaires 268Gemcitabine 267Standard of Care 266fludarabine 261Dexamethasone 258Drug Therapy 257venetoclax 247Bevacizumab 246Oxaliplatin 206Rituximab 196Capecitabine 196Radiation 189Fluorouracil 186Ipilimumab 185durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Surgery, Computer-Assisted × 1 year × Clear all
NCT06434909 2026-06-01

CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer

Indiana University

Phase 2 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT07315100 2026-01-02

Navigated Partial Nephrectomy

The Netherlands Cancer Institute

Phase NA Completed
20 enrolled
Genitourinary

Kidney Neoplasms

NCT03760575 2025-12-04

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Abramson Cancer Center at Penn Medicine

Phase 1 Recruiting
20 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡